SMAD3 and breast cancer: As shown in Fig. 6C, the TGF‐β‐induced EGFR expression was more strongly inhibited by the double suppression of Smad3 and Sp1 expression than by the single‐Sp1 or single‐Smad3 siRNA‐transfected breast cancer cells.